Genworth Financial (NYSE:GNW) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.20 by 65 percent. This is a 3.13 percent increase over earnings of $0.32 per share from the same period last year.
Artelo Biosciences Announces New Data On ART26.12 Demonstrating Effects In Multiple Models Of Neuropathic Pain At The 33rd Annual International Cannabinoid Research Society Symposium
ART26.12, a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor, Shows Favorable Results in Studies for Chemotherapy-Induced Neuropathy and Diabetic Neuropathy
ART26.12 targeting global neuropathic pain
